Dan Sturm is a Medical Director at Incyte with over 15 years of experience in medical affairs. He specializes in immuno-dermatology, currently leading the U. S. medical strategy for vitiligo. He holds a PharmD from the University of Rhode Island and an MBA from the University of Delaware.
He is passionate about bridging science and strategy to improve outcomes for patients suffering from immune-mediated skin diseases. His work involves extensive collaboration across medical, commercial, and market access teams to translate clinical insights into strategic impact.
He played a key role in the medical affairs strategy and evidence generation supporting the successful launch of ruxolitinib cream (Opzelura).
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Explore more public profiles from related professionals.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.